Objective: To report the use of sodium bicarbonate (SB) in out-of-hospital cardiac arrest (OHCA) and to explore the role of sodium bicarbonate in resuscitation of OHCA in terms of restoration of spontaneous circulation (ROSC) and survival, and existence of dose-dependent relationship, especially in those with prolonged arrest. Design: Retrospective cohort study. Setting: Emergency department of two regional hospitals in a cluster of Hong Kong. Methods: Adult patients aged at least 18 years old who presented to the study centres with non-traumatic OHCA in the period between March 2013 and December 2013 were included. Cases in which resuscitations were considered medically futile or not actually performed were excluded. Those with do-not-resuscitate (DNR) order or advance directives, those who were death before arrival with postmortem changes, and those who developed ROSC before or within 15 minutes of arrival were excluded from the study. Patients with known poisoning from tricyclic antidepressant or other sodium channel blockers were excluded from analysis if any. The primary outcome of this study was ROSC. Other outcome variables included survival to hospital admission (STA) and survival to hospital discharge (STD). Results: A total of 489 patients were included during the study period for analysis. We found that patients who received sodium bicarbonate injection (SB group) during CPR had a higher percentage of ROSC than those who did not (no-SB group) (60.8% vs 22.5%; p<0.001). The survival-to-admission rate was higher in the SB group (56.8%) compared with the contrary (21.4%). The difference of survival-to-discharge between the two groups did not reach statistical significance (4.1% in SB group and 2.9% in the no-SB group; p=0.484). The rate of ROSC was found to be dose dependent, being higher in higher dose of SB administration. The ROSC rate increased from no-SB (22.4%) to 57.1% if given 50 ml SB, and further to 64.1% if given ≥100 ml SB. Conclusions: Our study shows that the use of sodium bicarbonate in the CPR of OHCA is beneficial in ROSC. The effect is dose dependent, with better results in higher dose (>100 ml) of sodium bicarbonate; however, we fail to demonstrate its benefit for prolonged CPR cases (>30 minutes). (Hong Kong j.emerg. med. 2015;22:281-290) 2013 3 2013 12 ( >18 ) 15 489
Introduction
The use of sodium bicarbonate (SB) during cardiopulmonary resuscitation (CPR) was originally based on the belief of its action in correcting metabolic acidosis in cardiac arrest and hence improved the outcomes in cardiac arrest. 1 But the 1986 update of the AHA Guidelines had raised major reservations regarding the necessity, efficacy and side-effects of SB, 2 and the 1992, 3 2000 4 and 2010 5 versions had deemphasized its use. Some studies even showed hypernatraemia, alkalosis, and excess carbon dioxide production had been associated with sodium bicarbonate injection during CPR. 6 As a result, the 2010 American Heart Association guidelines for advanced cardiac life support did not recommend the routine use of sodium bicarbonate during CPR, except for pre-existing metabolic acidosis, hyperkalaemia, and tricyclic antidepressant intoxication. 5 All those studies and guidelines caused a marked decline in the use of SB, one of the major changes in the conduction of ACLS over the past 15 years. 7 The fact that practically all recent animal experiments demonstrated its beneficial effect on both short-and long-term outcome 8, 9 had been overlooked.
Despite the fact that the use of sodium bicarbonate during cardiopulmonary resuscitation had been controversial for years, studies delineating the role of SB in resuscitation of cardiopulmonary arrest were still scanty, particularly evidence from the Asian-pacific area. The role of SB in promoting restoration of spontaneous circulation (ROSC) and in improving long-term outcome has not been evaluated in a welldesigned controlled trial. 10 The outcome of cardiac arrest and CPR, not responding to early defibrillation and requiring ACLS, is still very poor. 11 Bar-Joseph et al reported that the resuscitation outcomes in emergency medical systems improved in correlation with the increased use of sodium bicarbonate during CPR. 12 Further studies and randomised controlled trials (RCTs) by Vukmir et al failed to demonstrate the benefit of buffer therapy in out-of-hospital cardiac arrest (OHCA), but it showed a trend towards an improvement in the outcomes of prolonged resuscitative efforts associated with the use of sodium bicarbonate. 13 In this study, we aimed to report the use of SB in OHCA in local emergency department and to explore the role of SB in resuscitation of OHCA in terms of ROSC and survival, and existence of dose-dependent relationship, especially in those with prolonged arrest.
Methods

Study design and setting
This was a retrospective observational study conducted at the emergency department of two regional hospitals in a cluster of Hong Kong. The cluster served a population of more than a million people. The daily v i s i t s o f t h e e m e r g e n c y d e p a r t m e n t s w e r e approximately 600 and 350 respectively. All cardiopulmonary arrest patients would be directed to either hospital according to the proximity. Prehospital The study was approved by the hospital ethics committee. The study protocol was reviewed and approved for exemption of informed consent.
Patient inclusion
We included all adult patients aged at least 18 years old who presented to the study centres with nontraumatic OHCA in the period between March 2013 and December 2013. Patients in which resuscitation would be considered medically futile by the in-charge physician and those who had not been resuscitated were excluded. Those with do-not-resuscitate (DNR) order or advance directives, those who were death before arrival with postmortem changes, and those who developed ROSC before or within 15 minutes of arrival were excluded from the study. Patients with known poisoning from tricyclic antidepressant or other sodium channel blockers were excluded from analysis if any. Figure 1 illustrated the patient enrollment of our study.
Data collection
For all patients with cardiac arrest, the attending physician would acquire the necessary data of prehospital management and resuscitation and submit to the local cardiac arrest registry. The in-hospital resuscitation details including the use of sodium bicarbonate, the dose and timing of administration, the acid-base and electrolyte status of the patients were retrieved and recorded. Whether the attending physician got experience or qualification of fellowship of emergency medicine was also retrieved to analyse the prescription practice. Patients' outcomes were traced by electronic hospital records.
Outcome measures
The primary outcome of this study was ROSC, which was defined as sustainable spontaneous circulation with palpable pulse for at least 10 minutes. Other outcome variables included survival to hospital admission (STA) and survival to hospital discharge (STD).
Statistical tests
The statistical software package IBM SPSS version 20 for Windows was employed for analysis. Ages was shown as mean and standard deviations within normal distribution and were compared with independent sample t-test for the two groups. Skewed continuous variables such as time factors were described with median and interquartile range (IQR). Values were compared with Mann-Whitney U test. Categorical variables were shown in proportions and percentages that were compared with Chi-square test. P value of less than 0.05 was taken to imply statistical significance. Dose-dependent relationship was shown in plots for various doses of SB on the outcome. Predictors of survivals were entered together with the use of SB to a binominal logistic regression model for confounding control. Potential predictors of ROSC in OHCA which was biologically plausible and reported in the literature were included in the model. Defibrillations were included in the model while presumed aetiology and initial rhythms were omitted due to significant overlap. SB was categorised with different doses of 50 ml and 100 ml or above. Patients who were not given SB were assigned as the reference group. Adjusted odd ratios were calculated along their confidence intervals. P values were calculated for individual predictors. To illustrate the effect of SB in the outcomes for patients with short versus long down time, relative risk of ROSC were calculated for two groups with arrest to ED arrival time <30 minutes and ≥30 minutes. Relative risk reduction, absolute risk reduction and the number need to treat of using SB to gain one ROSC were calculated along with the 95% confidence intervals.
Results
A total of 585 patients were recorded OHCA in the cardiac arrest registry from March 2013 to December 2013. Ninety-six patients were excluded with the study flow as shown in Figure 1 . A total of 489 patients were included during the study period for analysis, with a male predominance (59.1%) and a mean age of 71.8 years.
Patients were divided into two groups based on whether they were treated (SB group, n=74) or not treated (no-SB group, n=415) with sodium bicarbonate.
Comparing the two groups (Table 1) , there were differences in the demographic characteristics shown by statistical test. Patients with younger age, male gender, presumed cardiac aetiology, initial rhythm of VT/VF, those received defibrillation, and those being treated by fellow physician were more likely to be given SB.
For the prescription practice of SB by emergency physicians for OHCA, we found that patients with younger age were more likely to be given SB during CPR (65.9 vs 72.8 years old; p=0.025) ( Table 1) . For those patients with presumed cardiac cause of death, a higher proportion of them received SB during CPR (52.7% compared with non-cardiac 30.4%; p=0.001). SB was also more likely to be given for those OHCA patients with initial rhythm being VF / pulseless VT and for those who had received defibrillation (Table 1) .
We also found that the in-charge physician with fellowship in EM specialty had higher tendency to give SB to OHCA patients during CPR (47.3% in fellows vs 34.7% in non-fellows; p=0.038).
For those 74 patients who were given SB during CPR, 65 of them (87.8%) had blood gas and electrolytes taken ( Table 2 ). The median pH value was 6.92 and the median serum potassium level was 4.5. The mean dose of 8.4% SB was 81.9 ml while there were 39 patients (52.7%) received more than 100 ml SB (Table 2 ).
In the univariate analysis, patients who received sodium bicarbonate injection during CPR had a higher percentage of ROSC than those who did not (60.8% vs 22.5%; p<0.001). The survival-to-admission rate was higher in the SB group (56.8%) compared with the contrary (21.4%). The difference of survival-todischarge between the two groups did not reach statistical significance (4.1% in SB group and 2.9% in the no-SB group; p=0.484).
The rate of ROSC was found to be dose dependent, being higher in higher dose of SB administration. The ROSC rate increased from no-SB (22.4%) to 57.1% if given 50 ml SB, and further to 64.1% if given ≥100 ml SB (Figure 2 ).
In the logistic regression predicting ROSC (Table 3) , witnessed arrest (OR 3.30 p<0.001) and EMS response time (OR 0.94; p=0.026) were independent predictors of ROSC. In addition, with reference group of no-SB given, the odds ratio of ROSC in group of patients received 50 ml 8.4% SB was 2.87 (95% CI 1.16-7.08; p=0.022). The odds ratio was 4.9 (95% CI 2.27-10.59; p<0.001) when ≥100 ml 8.4% SB was given which was compatible with the dose-dependent relationship ( Figure 2 ).
Subgroup analysis on SB injection during prolonged CPR (arrest to ED arrival time ≥30 minutes) was shown in Table 4 . In both groups ROSC rate was higher when SB was given. The relative ratio of ROSC was 2.41 (1.49-3.91) in the prolonged arrest group while the value was 2.85 (2.06-3.93) in the contrary. The number need to treat (NNT) was comparable in both groups (3.2 and 2.5 respectively).
Discussion
After over 40 years of modern CPR, the outcome of OHCA was still very poor. The overall rate of ROSC of OHCA was less than 30%, with the survival to discharge rate of only about 3%. Local studies also showed the outcome of OHCA had been poor. [14] [15] [16] [17] [18] [19] Cardiopulmonary arrest acutely decreases cardiac output, coronary blood flow and respiration. Perfusion failure results in tissue hypoxia, depletion of high energy phosphate stores and anaerobic metabolism. All these conditions contribute to a mixed respiratory and metabolic acidosis during cardiopulmonary arrest. Bicarbonate functions as a physiological buffer. 20 Administration of sodium bicarbonate was regarded as an essential component in CPR for many years after modern CPR was introduced in clinical practice in the early 1960s. 1 Patients in cardiac arrest were often found to be acidotic. Multiple old animal studies demonstrated that myocardial function was compromised by acidosis 21, 22 and that Adrenaline was less effective in acidosis. 23, 24 Those facts made physiological sense that correction of acidosis should be beneficial in successful resuscitation. However administration of sodium bicarbonate during CPR simply reflected the presumption that the acidosis originating from ischaemic injury of cardiac arrest was of itself detrimental for successful resuscitation. 25 Levine et al had demonstrated that in some situations where there was acidosis, the acidosis was actually protective. More studies also demonstrated potential negative effects of sodium bicarbonate administration in CPR and postcardiac arrest conditions. 27 These included venous hypercapnoea with an increase of mixed venous CO2, 28 leading to a decrease of tissue intracellular pH, 29 circulator y congestion, hypernatraemia and hyperosmolality with brain damage. 30 It may also cause alkalosis, excess production of carbon dioxide, central venous acidosis with inactivation of adrenaline administration, and compromised coronary flow. 6, 21 Thus the American Heart Association recommended that sodium bicarbonate should not be used routinely in CPR. 3 Several international critical care organisations even recommended that sodium bicarbonate should be given Class 3 status (inappropriate, without scientific evidence of efficacy) for CPR. 31 Disparate opinions concerning the appropriate indications for use of sodium bicarbonate in patients with acidosis in cardiac arrest become an important topic in modern CPR. The American Heart Association certainly did not assign sodium bicarbonate as Class 3. It is a Class 1 for preexisting hyperkalaemia, Class 2a (likely to be beneficial) for preexisting metabolic acidosis or tricyclic or barbiturates overdose, and Class 2b (acknowledging the lack of well-established evidence) for prolonged cardiac arrest or upon RO S C . 3 T h e 1 9 9 2 Na t i o n a l C o n f e re n c e o n Cardiopulmonary Resuscitation and Emergency Cardiac Care classified sodium bicarbonate as a Class 2b intervention that could be used after prolonged intervals of cardiac arrest. 34, 35 However, these studies did not prove that SB worsened CPR outcome. They merely demonstrated that more SB was administered in more prolonged resuscitation, which were obviously associated with worse outcome. 36 The likelihood of successful defibrillation and resuscitation decreases as the duration of cardiac arrest increases. Prolonged cardiac arrest is also associated with more development of acidosis. 9 Our study showed the use of sodium bicarbonate in the CPR of OHCA was beneficial in ROSC, but failed to demonstrate its benefit during prolonged CPR. Vukmir et al and Leong et al showed in prolonged cardiac arrest, sodium bicarbonate administration improved the survival rate and neurological outcome in dogs. 8, 9 Bar-Joseph et al reported that the resuscitation outcomes in emergency medical systems improved in correlation with the increased use of SB during CPR. 12 Further studies and RCTs by Vukmir et al failed to demonstrate the benefit of buffer therapy in OHCA, but it showed a trend towards an improvement in the outcomes of prolonged resuscitative efforts associated with the use of sodium bicarbonate. 13 Mattar et al found that large amount of sodium bicarbonate administration in CPR resulted in severe hypernatraemia, hyperosmolality, increased lactic acidosis and 100% mortality rate. 37 But we found the rate of STA with the use of SB was dose dependent, being higher in higher dose of SB administration (about 100 to 200 ml 8.4% NaHCO3). However, the survival-to-discharge rate could not be assessed by this retrospective study with limited sample size.
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An observation about the prescription behaviour of SB in resuscitation is that generally physicians would be more likely to prescribe SB in those patients who were believed to have higher chance of survival e.g. younger patients, patients with cardiac cause of arrest, first rhythm in A&E being shockable, defibrillated, etc.
The use of sodium bicarbonate in CPR and whether to discard it during CPR was still a controversial topic. Our study showed the use of sodium bicarbonate in the CPR of OHCA was beneficial in ROSC, which was also dose dependent. But we failed to demonstrate its benefit on survival-to-discharge. The fact that many different studies demonstrated contradictory results making whether to use sodium bicarbonate or to discard it during CPR a serious dilemma in the management of OHCA. In the modern days of evidence-based medicine, we may need a large prospective clinical trial involving multi-centre to provide a more convincing answer and approach to the role of sodium bicarbonate in the CPR of OHCA.
Limitations
We used the rate of ROSC as a surrogate marker for cardiac arrest. STD should be a better outcome variable. However it was not feasible in our study due to the low STD rate. The relatively small simple size also limited the general applicability of this study. Furthermore, our study design is a retrospective cohort study where there is still possibility of uncontrolled residual confounders. A randomised controlled trial with adequate sample size would be better to illustrate the causal relationship and the role of SB in resuscitation of OHCA.
Conclusions
The use of sodium bicarbonate in CPR of OHCA and whether to discard it during CPR is still a controversial topic. There are still disparate opinions concerning the appropriate indications for use of sodium bicarbonate in the CPR of patients with cardiac arrest. Our study shows the use of sodium bicarbonate in the CPR of OHCA is beneficial in ROSC. The effect is dose dependent, with better results in higher dose (>100 ml) of SB. However, the effect is not demonstrated for cases with prolonged CPR (>30 minutes). As it is an important topic in modern CPR, a multi-centre large scale RCT should be done to give the answer.
